Abstract
Discussions of the question before this panel frequently take a disturbingly illogical course. I refer to the following common argument: the cholesterol hypothesis, we are told, has been before us for decades, and the possibility of prevention has been under study in man for twelve or fifteen years. These studies have not proved that dietary cholesterol-lowering can prevent coronary heart disease (CHD), and therefore, it is alleged, we should abandon this hypothesis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Stamler, J., in Lectures on Preventive Cardiology. Grune & Stratton, New York (1967), p. 109.
Gordon, T., and J. Verter, in The Framingham Study, Section 23. Serum cholesterol, systolic blood pressure, and Framingham relative weight as discriminators of cardiovascular disease. National Institutes of Health, (1969).
Rinzler, S. H. Bull. N.Y. Acad. Med. 44: 936 (1968).
Turpeinen, O. Atherosclerosis. Proceedings of the Second International Symposium on Atherosclerosis. Springer-Verlag, New York (1970), p. 572.
Dayton, S., M. L. Pearce, S. Hashimoto, W. J. Dixon, and U. Tomiyasu. American Heart Association Monograph No. 25, (1969).
Pearce, M. L., and S. Dayton. Lancet 1: 464 (1971)
Gammal, E. B., K. K. Carroll, and E. R. Plunkett. Cancer Res. 24: 1737 (1967).
Carroll, K. K., and H. T. Khor. Cancer Res. 30: 2260 (1970).
Ederer, F., P. Leren, O. Turpeinen, and I. D. Frantz, Jr. Lancet II: 203 (1971).
Keys, A. (Ed.) American Heart Association Monograph No. 29, (1970).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1972 Springer Science+Business Media New York
About this chapter
Cite this chapter
Dayton, S. (1972). Cholesterol-Lowering in Man. In: Holmes, W.L., Paoletti, R., Kritchevsky, D. (eds) Pharmacological Control of Lipid Metabolism. Advances in Experimental Medicine and Biology, vol 26. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7547-0_20
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7547-0_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7549-4
Online ISBN: 978-1-4684-7547-0
eBook Packages: Springer Book Archive